Prevatex awarded $85,000 grant

Prevatex has been awarded a collaborative grant worth more than $85,000 from the University of Sydney.

Prevatex completes initial R&D goals

This is a pivotal publication in a leading international journal, which clearly shows that maternal P. copri plays a key role in the development of immune responses and resulting allergies in infants.

Prevatex completes founder capital raise

This is a pivotal publication in a leading international journal, which clearly shows that maternal P. copri plays a key role in the development of immune responses and resulting allergies in infants.